FDA approves first therapy for symptomatic dermographism

• by Teraya Smith

• October 7, 2026

Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis”

• by Kim Rand, Kurt Gebauer, Yousef Binamer, Yung-Tsu Cho, Manny Papadimitropoulos, Chao Yang, Helena Agell, Bülent Akmaz, Lucia Seminario-Vidal

• June 26, 2026

High progesterone may be tied to syringoma

Elevated levels occurred in 29% of women with the condition compared with 6% of controls in a cross-sectional study.

• by Andrea Surnit

• August 31, 2026

• 3 min

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

• by Kathryn Wighton

• May 27, 2026

• 5 min